Bartkova J - Search Results

1

Selective Loss of PARG Restores PARylation and Counteracts PARP Inhibitor-Mediated Synthetic Lethality.

Gogola E, Duarte AA, de Ruiter JR, Wiegant WW, Schmid JA, de Bruijn R, James DI, Guerrero Llobet S, Vis DJ, Annunziato S, van den Broek B, Barazas M, Kersbergen A, van de Ven M, Tarsounas M, Ogilvie DJ, van Vugt M, Wessels LFA, Bartkova J, Gromova I, Andújar-Sánchez M, Bartek J, Lopes M, van Attikum H, Borst P, Jonkers J, Rottenberg S. Gogola E, et al. Among authors: bartkova j. Cancer Cell. 2018 Jun 11;33(6):1078-1093.e12. doi: 10.1016/j.ccell.2018.05.008. Cancer Cell. 2018. PMID: 29894693 Free article.

2

Studies of clonal cell lines developed from primary breast cancers indicate that the ability to undergo morphogenesis in vitro is lost early in malignancy.

Shearer M, Bartkova J, Bartek J, Berdichevsky F, Barnes D, Millis R, Taylor-Papadimitriou J. Shearer M, et al. Among authors: bartkova j. Int J Cancer. 1992 Jun 19;51(4):602-12. doi: 10.1002/ijc.2910510417. Int J Cancer. 1992. PMID: 1376300

3

Keratin 19 expression in the adult and developing human mammary gland.

Bartek J, Bartkova J, Taylor-Papadimitriou J. Bartek J, et al. Among authors: bartkova j. Histochem J. 1990 Oct;22(10):537-44. doi: 10.1007/BF01005976. Histochem J. 1990. PMID: 1705251

4

Selective immortalization of a phenotypically distinct epithelial cell type by microinjection of SV40 DNA into cultured human milk cells.

Bartek J, Bartkova J, Lalani EN, Brezina V, Taylor-Papadimitriou J. Bartek J, et al. Among authors: bartkova j. Int J Cancer. 1990 Jun 15;45(6):1105-12. doi: 10.1002/ijc.2910450620. Int J Cancer. 1990. PMID: 2161799

5

Aberrations of p16Ink4 and retinoblastoma tumour-suppressor genes occur in distinct sub-sets of human cancer cell lines.

Aagaard L, Lukas J, Bartkova J, Kjerulff AA, Strauss M, Bartek J. Aagaard L, et al. Among authors: bartkova j. Int J Cancer. 1995 Mar 29;61(1):115-20. doi: 10.1002/ijc.2910610120. Int J Cancer. 1995. PMID: 7705923

6

Cyclin D1 is dispensable for G1 control in retinoblastoma gene-deficient cells independently of cdk4 activity.

Lukas J, Bartkova J, Rohde M, Strauss M, Bartek J. Lukas J, et al. Among authors: bartkova j. Mol Cell Biol. 1995 May;15(5):2600-11. doi: 10.1128/MCB.15.5.2600. Mol Cell Biol. 1995. PMID: 7739541 Free PMC article.

7

Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16.

Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J. Lukas J, et al. Among authors: bartkova j. Nature. 1995 Jun 8;375(6531):503-6. doi: 10.1038/375503a0. Nature. 1995. PMID: 7777060

8

Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types.

Lukas J, Bartkova J, Welcker M, Petersen OW, Peters G, Strauss M, Bartek J. Lukas J, et al. Among authors: bartkova j. Oncogene. 1995 Jun 1;10(11):2125-34. Oncogene. 1995. PMID: 7784057

9

Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer.

Bartkova J, Lukas J, Müller H, Strauss M, Gusterson B, Bartek J. Bartkova J, et al. Cancer Res. 1995 Feb 15;55(4):949-56. Cancer Res. 1995. PMID: 7850812

10

Cyclin D1 oncoprotein aberrantly accumulates in malignancies of diverse histogenesis.

Bartkova J, Lukas J, Strauss M, Bartek J. Bartkova J, et al. Oncogene. 1995 Feb 16;10(4):775-8. Oncogene. 1995. PMID: 7862456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

161 results

Search Page

Filters